Claritas Pharmaceuticals, Inc. (CLAZF)

Market Cap	38.00 -100.0%
Revenue (ttm)	n/a
Net Income	-4.72M
EPS	-0.13
Shares Out	37.79M
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,203
Average Volume	2,701
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0000
Beta	38.61
RSI	45.58
Earnings Date	n/a

About Claritas Pharmaceuticals

Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. Claritas Pharmaceuticals, Inc. was founded in 2014 and is based in San Rafael, California.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLAZF